(19)
(11) EP 2 994 130 A1

(12)

(43) Date of publication:
16.03.2016 Bulletin 2016/11

(21) Application number: 13884155.6

(22) Date of filing: 06.05.2013
(51) International Patent Classification (IPC): 
A61K 31/405(2006.01)
A61K 31/506(2006.01)
A61K 31/513(2006.01)
A61K 31/5025(2006.01)
A61K 31/365(2006.01)
A61K 31/496(2006.01)
A61K 31/4709(2006.01)
A61K 31/519(2006.01)
A61K 31/403(2006.01)
A61P 43/00(2006.01)
(86) International application number:
PCT/US2013/039758
(87) International publication number:
WO 2014/182277 (13.11.2014 Gazette 2014/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(71) Applicant: Bush, Andrew B.
Princeton, New Jersey 08540 (US)

(72) Inventor:
  • Bush, Andrew B.
    Princeton, New Jersey 08540 (US)

(74) Representative: Care, Alison et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)

   


(54) FGF MODULATION OF IN VIVO ANTIBODY PRODUCTION AND HUMORAL IMMUNITY